INCY
#499
Incyte Corporation - Common Stock
128.8 3 USD
+0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.06%
Monthly Change
+8.19%
6 month change
+29.92%
Year Change
+47.64%
Previous Close
125.0 1
Open
128.8 3
Low
128.8 3
High
128.8 3
Volume
219
Financials
- Market Capitalization 26.11 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
14.44
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 474 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 63.11 USD | +1.27% | +2.75% | +10.39% | +69.38% | 28.18 B USD | ||
| 483 |  INSM Insmed Incorporated - Common Stock | 126.63 USD | +4.21% | +1.71% | +27.52% | -21.86% | 27.65 B USD | ||
| 510 |  BNTX BioNTech SE - American Depositary Shares | 103.81 USD | +1.82% | -7.06% | +16.41% | +3.29% | 24.91 B USD | ||
| 514 |  ROIV Roivant Sciences Ltd. - Common Shares | 34.18 USD | -0.98% | -6.61% | +1.33% | +86.67% | 24.69 B USD |
Frequently asked questions about Incyte Genomics Inc
What is the Incyte Genomics Inc stock price today?
The current price of Incyte Genomics Inc (INCY) is 128.83. Over the past 24 hours, the stock has changed by +3.06%. Follow the INCY chart for real-time price dynamics.
What is the stock ticker of Incyte Genomics Inc?
Incyte Genomics Inc trades under the ticker INCY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Incyte Genomics Inc stock going up?
INCY has changed by +1.43% over the last week, +8.19% over the last month, and +47.64% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Incyte Genomics Inc?
Incyte Genomics Inc currently has a market capitalization of 26.11 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Incyte Genomics Inc earnings last quarter?
Last quarter, Incyte Genomics Inc reported earnings of 2.92 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Incyte Genomics Inc revenue for the last quarter?
Incyte Genomics Inc reported quarterly revenue of 1.67 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Incyte Genomics Inc net income for the last quarter?
Incyte Genomics Inc reported net income of 585.61 M for the last quarter. The previous quarter showed 303.33 M, which means net income changed by +93.06%.
How many employees does Incyte Genomics Inc have?
As of the latest available data, Incyte Genomics Inc has 2 844 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Incyte Genomics Inc stock?
You can buy Incyte Genomics Inc (INCY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Incyte Genomics Inc stock?
Investing in Incyte Genomics Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INCY chart and related analysis on metatrader.com as part of your research.